Cambridge Trust Co. Grows Holdings in Celsius Holdings, Inc. (NASDAQ:CELH)

Cambridge Trust Co. increased its position in Celsius Holdings, Inc. (NASDAQ:CELH) by 280.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 570 shares of the company’s stock after purchasing an additional 420 shares during the period. Cambridge Trust Co.’s holdings in Celsius were worth $31,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Oliver Lagore Vanvalin Investment Group boosted its stake in Celsius by 443.6% in the 4th quarter. Oliver Lagore Vanvalin Investment Group now owns 13,801 shares of the company’s stock worth $752,000 after purchasing an additional 11,262 shares in the last quarter. Daiwa Securities Group Inc. boosted its stake in Celsius by 388.1% in the 4th quarter. Daiwa Securities Group Inc. now owns 16,375 shares of the company’s stock worth $892,000 after purchasing an additional 13,020 shares in the last quarter. Phoenix Wealth Advisors boosted its stake in Celsius by 200.0% in the 4th quarter. Phoenix Wealth Advisors now owns 7,440 shares of the company’s stock worth $439,000 after purchasing an additional 4,960 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Celsius by 238.8% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 27,443 shares of the company’s stock worth $1,496,000 after purchasing an additional 19,343 shares in the last quarter. Finally, Desjardins Global Asset Management Inc. bought a new position in Celsius in the 4th quarter worth about $55,000. Institutional investors own 60.95% of the company’s stock.

Insider Buying and Selling

In related news, CFO Jarrod Langhans sold 4,079 shares of the stock in a transaction that occurred on Friday, April 19th. The shares were sold at an average price of $69.42, for a total value of $283,164.18. Following the completion of the sale, the chief financial officer now directly owns 83,670 shares of the company’s stock, valued at approximately $5,808,371.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Celsius news, major shareholder William H. Milmoe sold 129,658 shares of the stock in a transaction that occurred on Monday, January 22nd. The shares were sold at an average price of $47.49, for a total transaction of $6,157,458.42. Following the completion of the sale, the insider now directly owns 31,413,662 shares of the company’s stock, valued at approximately $1,491,834,808.38. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Jarrod Langhans sold 4,079 shares of the firm’s stock in a transaction on Friday, April 19th. The shares were sold at an average price of $69.42, for a total transaction of $283,164.18. Following the completion of the transaction, the chief financial officer now directly owns 83,670 shares of the company’s stock, valued at $5,808,371.40. The disclosure for this sale can be found here. In the last ninety days, insiders sold 1,038,400 shares of company stock valued at $60,947,637. 2.70% of the stock is owned by corporate insiders.

Celsius Stock Down 1.6 %

Shares of NASDAQ:CELH opened at $68.84 on Friday. The firm’s 50 day moving average price is $78.80 and its 200-day moving average price is $64.14. Celsius Holdings, Inc. has a twelve month low of $29.42 and a twelve month high of $99.62. The stock has a market capitalization of $15.90 billion, a PE ratio of 89.02, a price-to-earnings-growth ratio of 2.04 and a beta of 1.86.

Celsius (NASDAQ:CELH) last released its earnings results on Thursday, February 29th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $347.44 million during the quarter, compared to analyst estimates of $326.77 million. Celsius had a net margin of 17.21% and a return on equity of 131.58%. The firm’s quarterly revenue was up 95.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.01 EPS. Analysts expect that Celsius Holdings, Inc. will post 1.09 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have issued reports on CELH shares. Maxim Group upped their target price on shares of Celsius from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. UBS Group upped their target price on shares of Celsius from $73.00 to $99.00 and gave the company a “buy” rating in a research note on Friday, March 1st. Wedbush upped their target price on shares of Celsius from $75.00 to $90.00 and gave the company an “outperform” rating in a research note on Monday, March 4th. Roth Mkm upped their target price on shares of Celsius from $90.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, March 14th. Finally, Stifel Europe upped their target price on shares of Celsius from $90.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, March 18th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $85.10.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.